Rehabilitation for people recovering from tuberculosis lung disease
Rehabilitation of People With Post-tuberculosis Lung Disease
NA · Centro Universitário Augusto Motta · NCT06127641
This study is testing if a 12-week rehabilitation program can help people recovering from tuberculosis lung disease feel better and improve their daily activities compared to standard care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centro Universitário Augusto Motta (other) |
| Locations | 2 sites (Rio de Janeiro and 1 other locations) |
| Trial ID | NCT06127641 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of pulmonary rehabilitation on the functionality and health-related quality of life of individuals suffering from post-tuberculosis lung disease (PD-PTB). It involves a randomized controlled trial where participants will be divided into two groups: one receiving standard care and the other undergoing a 12-week pulmonary rehabilitation program. The study will assess functional capacity using the Glittre-ADL test, along with evaluations of lung function, muscle function, fatigue, and overall quality of life. Additionally, an artificial intelligence-based scoring system for PD-PTB severity will be developed based on the collected data.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with clinically stable post-tuberculosis lung disease who can participate in at least 80% of the training sessions.
Not a fit: Patients with significant comorbidities unrelated to PD-PTB or those unable to perform the required tests may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life and functional capabilities of patients recovering from tuberculosis lung disease.
How similar studies have performed: Other studies have shown promising results with pulmonary rehabilitation in similar patient populations, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with post-tuberculosis lung disease, clinically stable and able to perform \>80% of training sessions. Exclusion Criteria: * Presence of comorbidities not related to PD-PTB. * Patients with inability to perform TGlittre. * Patients who have cognitive changes that impair their inclusion in the study. * Treatment abandonment during the application of the PR protocol. * Uncontrolled hypertension or use of psychotropic medications. * Any significant limitations due to osteoarthropathy. * Having had any orthopedic surgery in the previous year.
Where this trial is running
Rio de Janeiro and 1 other locations
- Agnaldo José Lopes — Rio de Janeiro, Brazil (RECRUITING)
- Centro Universitario Augusto Motta — Rio de Janeiro, Brazil (RECRUITING)
Study contacts
- Study coordinator: Agnaldo José Lopes, DsC
- Email: agnaldolopes.uerj@gmail.com
- Phone: +55 21998536162
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Tuberculosis, Pulmonary tuberculosis, Tuberculosis sequelae, Rehabilitation, ADL-Glittre test, Functionality, Quality of life